Trudel new chief executive at Encision
Last Updated: 15:43 December 18, 2013
Trudel will start working at Encision (ECIA: PK) on Monday, Dec. 23, according to the company. Encision makes and sells surgical devices used in minimally invasive surgery.
Patrick W. Pace, executive chairman of the company, said Trudel brings a legacy of success and fresh energy to Encision.
Trudel previously was the global director of marketing for Covidien Plc. Prior to that he held leadership roles with ConMed Corp.'s electrosurgery division, SilverGlide Surgical Technologies Inc. and Stryker Corp.
Encision said Wednesday that it raised $2 million through a private placement of 2.5 million shares of its common stock.
The private placement represents 23 percent of the total number of shares in the company. The purchase price per share was 80 cents. Proceeds will be used for general corporate purposes, the company said in a statement.
More breaking news...
OIA likes proposed budget for public lands
Boulder Brands outlines 2014 for investors
TekDry attracts cash to save wet cellphones
Fresh off of a glowing 2013 earnings report that showed profit had more than doubled
According to a document filed with the